BioSpace News Archive

Drug Development

CV Therapeutics, Inc. Completes Enrollment Of Second Regadenoson Phase 3 Trial

June 7, 2006
·
4 min read
Biotech Beach

Sybron Dental Specialties, Inc. Announces Early Results And The Pricing Terms In Connection With Its Tender Offer And Consent Solicitation For Its 8.125% Senior Subordinated Notes Due 2012

June 7, 2006
·
1 min read
Biotech Beach

Diagnostic Products Corporation Announces Record Date And Shareholder Meeting Date

June 7, 2006
·
1 min read
Drug Development

Peregrine Pharmaceuticals, Inc.'s Bavituximab Shows Promising Anti-Viral Activity And Signs Of Prolonged Anti-Viral Effect In Single Dose Monotherapy HCV Trial

June 7, 2006
·
1 min read
Business

Pharsight Corporation And FDA Collaborate On Critical Path Initiative To Implement State-Of-The-Art Infrastructure For Model-Based Drug Development

June 7, 2006
·
1 min read
Biotech Bay

Pharsight Corporation To Present OnOncology Modeling And Simulation At June 15, 2006 Page Annual Meeting

June 7, 2006
·
1 min read
Biotech Bay

Pharsight Corporation To Present On HIV Modeling And Simulation At June 15, 2006 Page Annual Meeting

June 7, 2006
·
1 min read
Deals

Novartis Corporation To Buy Superbug Firm NeuTec Pharma plc For $569 Million

June 7, 2006
·
1 min read
Policy

Discovery Laboratories Withdraws Application For Surfaxin

June 7, 2006
·
7 min read
FDA

Abbott Laboratories’s HUMIRA(R) (Adalimumab) Approved In The European Union For Treatment Of Severe Ankylosing Spondylitis

June 7, 2006
·
1 min read